Pfizer, BioNTech launch phase 1 trial on combined COVID-19 and flu vaccine

Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday. The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and…








